Dalrada Financl Stock Price, News & Analysis

Dalrada Financial (OTC PINK:DFCO) announced that its subsidiary Deposition Technology's (Deptec) proprietary plasma spectrometer, Spectroptix®, is now available for advance ordering. The device is designed for precise element detection in vacuum chambers during deposition or semiconductor manufacturing processes.

Key features include real-time actionable data delivery, background plasma creation without process contamination, enhanced process control, and a user-friendly interface with remote operation capabilities. The spectrometer is positioned as a more cost-effective alternative to Residual Gas Analyzers (RGAs).

The technology targets applications in semiconductor manufacturing, microelectronics, optoelectronics, and advanced material processing, with future expansion planned into pharmaceuticals, aerospace/defense, materials science, nuclear industries, and food and beverage sectors.

Dalrada Financial (OTC PINK:DFCO) has announced the election of Roger Campos to its board of directors. Campos, the Chairman and Founder of Minority Business RoundTable (MBRT), brings extensive business and government experience to the company. His background includes four years of service in the White House and roles as Special Assistant to the Secretary of Energy and Special Consultant to the U.S. Small Business Administration.

CEO Brian Bonar emphasized that Campos will provide expert guidance and strengthen the company's position in core business sectors, particularly in strategic initiatives within state and federal governments. Campos recently served as Assistant Secretary for Business Development in Maryland's Department of Housing and Community Development from 2015 to 2023.

Dalrada Financial (OTCQB:DFCO) announces the establishment of a new state-of-the-art manufacturing and R&D facility in Portland, Oregon for Deposition Technology USA (Deptec). The facility will serve as U.S. headquarters for advanced thin-film deposition solutions and support growing market demand. The site will produce Physical Vapor Deposition (PVD) and Chemical Vapor Deposition (CVD) systems, including Spectroptix for precise thin-film deposition. Additionally, it will function as a testing and production facility for Dalrada's DCT One Series CO₂ heat pumps and advance R&D for the DCT Two Series.

Dalrada Financial (OTCQB:DFCO) has appointed CM3 Advisory as its new independent registered public accounting firm. CM3, a PCAOB auditing firm, will be responsible for auditing Dalrada's consolidated financial statements for the 2024 fiscal year and subsequent quarters. CM3 brings expertise in assurance, advisory, and tax services across multiple sectors including manufacturing, technology, aerospace, and private equity, with experience in mergers and acquisitions and exit planning.

Dalrada Financial (OTCQB:DFCO) has announced that it is actively interviewing several PCAOB auditing firms to replace Assurance Dimensions. The company expects to engage a new auditor shortly and file its Form 10-K for the year ending June 30, 2024. Assurance Dimensions resigned on October 11, 2024, just two business days before the Form 10-K filing deadline. They were originally engaged to review financials for Q1 2024 and audit the consolidated financial statements for FY 2024 and subsequent quarters.

CEO Brian Bonar emphasized the importance of maintaining agility and adaptability in the face of challenges, especially for a rapidly growing company. He expressed eagerness to find a new audit partner who understands Dalrada's diverse operations and can support its future growth.

Dalrada Financial (OTCQB:DFCO) has announced the appointment of Pauline Gourdie as Chief of Staff by CEO and Chairman Brian Bonar. Gourdie, with extensive experience at Fortune 500 companies like IBM and Lenovo, is expected to enhance operational efficiency and drive global success. Her role includes strategic planning, operational oversight, project coordination, and crisis management.

Gourdie's international experience aligns with Dalrada's immediate and long-term growth goals, particularly in its existing locations in California, Texas, Spain, Scotland, the UK, France, and North Africa. She currently serves as the Vice Chair of Dalrada's Board of Directors and owns CSL Staffing. With over 20 years of experience in supply chain management, customer relations, and team leadership, Gourdie holds a BS in Industrial and Labor Relations from Cornell University.

Dalrada Financial (OTCQB:DFCO) has signed a contract with Onet Group, a global building maintenance services leader, for the purchase and installation of Dalrada heat pumps in a Spanish light industrial facility. The initial contract, valued at 260,000 euros, marks the beginning of a potentially expansive partnership. Dalrada is already in the design phase for two additional Onet client installations.

This agreement opens doors to Onet's 140 managed facilities across France and Spain, aligning with both companies' commitment to sustainability. The partnership aims to help Onet's clients meet new European efficiency and emissions standards. Revenues from this contract will be reflected in Dalrada's September quarter, potentially signaling the start of significant growth in the European market.

Dalrada Financial (OTCQB:DFCO) has finalized an exclusive master distribution agreement with Applied Technologies of New York (ATI) for its heat pump technology. The three-year agreement targets initial sales of 75 units in the first 18 months, escalating to 600 units in the following year. ATI will distribute Dalrada's heat pumps across major U.S. cities, including Boston, New York, Atlanta, Miami, and Chicago. This partnership aligns with New York's goal to reduce greenhouse gas emissions by 85% by 2050, positioning Dalrada to capitalize on the growing heat pump market driven by state incentives and high energy costs.

Genefic, Inc., a subsidiary of Dalrada Financial (OTCQB:DFCO), has released a new video interview featuring CEO Dan Riley. The interview highlights Genefic's significant revenue growth and success in the specialty pharmacy space since its launch in October 2023. Riley discusses the company's impressive quarterly performance, with revenue jumping from $4 million to $8 million in consecutive quarters.

The interview also covers Genefic's expansion strategy, which includes two licensed diagnostic laboratories, a 50-state licensed specialty pharmacy, and a recently-acquired infusion pharmacy in the New Orleans area. Riley emphasizes the company's goal to become a one-stop shop for all pharmacy services and verticals, potentially entering the compounding pharmacy market as well.